Results 221 to 230 of about 95,168 (297)
Intralesional acyclovir versus intralesional Hepatitis-B vaccine in treatment of resistant plantar warts: a randomized controlled trial. [PDF]
Gharib K, Taha A, Elradi M.
europepmc +1 more source
Synergistic Strategies in Systemic Therapy for Advanced Hepatocellular Carcinoma
This article comprehensively examines the evolving landscape of systemic therapy for advanced hepatocellular carcinoma. It covers the progress in tyrosine kinase inhibitors and immune checkpoint inhibitors, analyzes the efficacy of novel combination strategies, and discusses current challenges like drug resistance and the lack of biomarkers.
Yongxin Yu +5 more
wiley +1 more source
Global Health Initiatives and Universal Health Coverage in Pakistan‐Aligned for the Future?
ABSTRACT There is increasing global discourse on Global Health Initiatives' (GHIs) role and the need for better alignment with universal health coverage (UHC), which is particularly salient given recent rapid reductions in global aid. However, tensions within national ecosystems of GHI assistance and country alignment towards UHC are less well ...
Shehla Zaidi +8 more
wiley +1 more source
Hepatitis B vaccine effectiveness among vaccinated children in Africa: a systematic review and meta-analysis. [PDF]
Geta M, Yizengaw E, Manyazewal T.
europepmc +1 more source
ABSTRACT Background and Aims Procedures used by beauticians pose a significant risk of transmitting blood‐borne viruses, including hepatitis B virus (HBV) and hepatitis C virus (HCV). Despite this risk, data on HBV and HCV prevalence and knowledge among beauticians in Ghana are limited.
Kezia Y. Awortwe +5 more
wiley +1 more source
Hepatitis B Vaccine Refusal Trends in Washington, DC, Newborns, 2017-2022.
Yang YT, Leslie TF, Delamater PL.
europepmc +1 more source
Immune response to hepatitis B vaccine among children under 5 years in Africa: a meta-analysis. [PDF]
Olakunde BO +6 more
europepmc +1 more source
The hepatitis B vaccine: utilization decision process and outcomes in community hospitals. [PDF]
Bradford Kirkman‐Liff +2 more
openalex
ABSTRACT Background and Aims Anti‐PD‐1/PD‐L1 immunotherapy has changed the treatment landscape of lung cancer. This new approach provides the ability to revitalize the immune system to specifically target and kill cancer cells, thereby creating a new treatment paradigm for patients with non‐small cell lung cancer (NSCLC).
Md Mohiuddin
wiley +1 more source

